Invesco reports 2.397M shares (4.9%) of Charles River
Charles River Laboratories International Inc ownership disclosure: Invesco Ltd. reports beneficial ownership of 2,397,252 shares of Common Stock, representing 4.9% of the class.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Charles River Laboratories International Inc ownership disclosure: Invesco Ltd. reports beneficial ownership of 2,397,252 shares of Common Stock, representing 4.9% of the class. The filing states Invesco Ltd. has sole voting power over 2,387,914 shares and sole dispositive power over 2,397,252 shares; the shares are held of record by clients of Invesco Ltd.
Insights
Large passive holding disclosed; voting and dispositive powers are nearly aligned.
Invesco Ltd. reports beneficial ownership of 2,397,252 shares (4.9%). The filing attributes record ownership to client accounts, with 2,387,914 shares under sole voting power and 2,397,252 under sole dispositive power.
Because the position is below 5% and appears held for client accounts, this is a routine institutional disclosure; subsequent filings would show any material changes in stake or voting alignment.
Key Figures
Key Terms
beneficially own regulatory
sole dispositive power regulatory
Schedule 13G/A regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Invesco Ltd. report in Charles River (CRL)?
How much voting power does Invesco Ltd. have in CRL?
Does this Schedule 13G/A indicate an active intent to influence CRL management?
AI-generated analysis. How Rhea-AI works. Not financial advice.